From Bettina Bauer, Vice President, US HIV Treatment and Prevention, Gilead Sciences In 2022, there were up to 1.2 million ...

Data from a phase Ia clinical trial of an oral, long-acting integrase inhibitor (GS-1720) in development for HIV demonstrated ...

A research program that's paying cash to people who inject drugs is raising concerns for some residents and business owners.

The National Agency for the Control of AIDS (NACA), on Wednesday, lamented that Ogun State, despite efforts to reduce the ...

A sign for free HIV testing sits in front of JASMYN’s clinic and administration building in Jacksonville. Bob Self/Florida ...

A University of New Mexico researcher and assistant professor is breaking barriers in the health community for fellow Native Americans. Hailing from the Diné Nation, Crystal Lee has been researching ...

Gilead (GILD) reported positive results from a pivotal Phase 3 study of its twice-yearly HIV prevention treatment lenacapavir ...

A Hong Kong biotech company said its therapeutic HIV vaccine showed “promising” results in a recent clinical trial, taking it ...

Any new HIV prevention method is not meant to sit on the shelf but to be used by the people who need it to protect themselves ...

In honor of World AIDs Day, the Coastal Health District (CHD) is offering three free HIV testing events in Savannah. At two ...

Nebraska football head coach says that bringing Dana Holgorsen aboard as offensive coordinator is all about getting the ...

Westport failed to provide a resident medication to treat advanced HIV for three weeks, resulting in "significant medication ...